Benitec Ltd, a specialized in RNA interference (RNAi) technology got a patent grant at USPTO for its "RNAi Expression Constructs". The granted US Patent having no. 7803611 is related to RNAi costruct using single promoter for targeting hepatitis C virus to inhibit the level of hepatitis C virus in cells, tissues and organs.
Further the USPTO has also granted 925 days of patent term extension against delay in the examination activity at USPTO.
(Source: Pharmabiz)
No comments:
Post a Comment